Home Healthcare Biotechnology Organoids and Spheroids Market

Organoids and Spheroids Market Size, Share & Trends Analysis Report By Type (Organoids, Neural Organoids, Hepatic Organoids, Intestinal Organoids), By Spheroids (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity and Efficacy Testing), By End-user (Biotechnology and Pharmaceutical Industries, Academic and Research Institutes, Hospitals and Diagnostic Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Dhanashri B | Format: | Report Code: SR1199DR | Pages: 155
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Organoids and Spheroids Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Organoids
    2. Neural Organoids
    3. Hepatic Organoids
    4. Intestinal Organoids
  2. Organoids and Spheroids Market, By Spheroids 2022-2034 (USD MILLION/ Units)
    1. Multicellular Tumor Spheroids (MCTS)
    2. Neurospheres
    3. Mammospheres
    4. Hepatospheres 
    5. Embryoid bodies
  3. Organoids and Spheroids Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Developmental Biology
    2. Personalized Medicine
    3. Regenerative Medicine
    4. Disease Pathology Studies
    5. Drug Toxicity and Efficacy Testing
  4. Organoids and Spheroids Market, By End-user 2022-2034 (USD MILLION/ Units)
    1. Biotechnology and Pharmaceutical Industries
    2. Academic and Research Institutes
    3. Hospitals and Diagnostic Centers
  5. Regional Organoids and Spheroids Market
    1. North America
      1. North America Organoids and Spheroids Market By Type 2022-2034 (USD MILLION/ Units)
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
      2. North America Organoids and Spheroids Market By Spheroids 2022-2034 (USD MILLION/ Units)
        1. Multicellular Tumor Spheroids (MCTS)
        2. Neurospheres
        3. Mammospheres
        4. Hepatospheres 
        5. Embryoid bodies
      3. North America Organoids and Spheroids Market By Application 2022-2034 (USD MILLION/ Units)
        1. Developmental Biology
        2. Personalized Medicine
        3. Regenerative Medicine
        4. Disease Pathology Studies
        5. Drug Toxicity and Efficacy Testing
      4. North America Organoids and Spheroids Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Biotechnology and Pharmaceutical Industries
        2. Academic and Research Institutes
        3. Hospitals and Diagnostic Centers
      5. U.S.
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      6. Canada
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
    2. Europe
      1. Europe Organoids and Spheroids Market By Type 2022-2034 (USD MILLION/ Units)
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
      2. Europe Organoids and Spheroids Market By Spheroids 2022-2034 (USD MILLION/ Units)
        1. Multicellular Tumor Spheroids (MCTS)
        2. Neurospheres
        3. Mammospheres
        4. Hepatospheres 
        5. Embryoid bodies
      3. Europe Organoids and Spheroids Market By Application 2022-2034 (USD MILLION/ Units)
        1. Developmental Biology
        2. Personalized Medicine
        3. Regenerative Medicine
        4. Disease Pathology Studies
        5. Drug Toxicity and Efficacy Testing
      4. Europe Organoids and Spheroids Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Biotechnology and Pharmaceutical Industries
        2. Academic and Research Institutes
        3. Hospitals and Diagnostic Centers
      5. U.K.
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      6. Germany
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      7. France
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      8. Spain
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      9. Italy
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      10. Russia
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      11. Nordic
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      12. Benelux
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      13. Rest of Europe
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
    3. APAC
      1. APAC Organoids and Spheroids Market By Type 2022-2034 (USD MILLION/ Units)
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
      2. APAC Organoids and Spheroids Market By Spheroids 2022-2034 (USD MILLION/ Units)
        1. Multicellular Tumor Spheroids (MCTS)
        2. Neurospheres
        3. Mammospheres
        4. Hepatospheres 
        5. Embryoid bodies
      3. APAC Organoids and Spheroids Market By Application 2022-2034 (USD MILLION/ Units)
        1. Developmental Biology
        2. Personalized Medicine
        3. Regenerative Medicine
        4. Disease Pathology Studies
        5. Drug Toxicity and Efficacy Testing
      4. APAC Organoids and Spheroids Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Biotechnology and Pharmaceutical Industries
        2. Academic and Research Institutes
        3. Hospitals and Diagnostic Centers
      5. China
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      6. Korea
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      7. Japan
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      8. India
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      9. Australia
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      10. Taiwan
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      11. South East Asia
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      12. Rest of Asia-Pacific
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
    4. Middle East and Africa
      1. Middle East and Africa Organoids and Spheroids Market By Type 2022-2034 (USD MILLION/ Units)
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
      2. Middle East and Africa Organoids and Spheroids Market By Spheroids 2022-2034 (USD MILLION/ Units)
        1. Multicellular Tumor Spheroids (MCTS)
        2. Neurospheres
        3. Mammospheres
        4. Hepatospheres 
        5. Embryoid bodies
      3. Middle East and Africa Organoids and Spheroids Market By Application 2022-2034 (USD MILLION/ Units)
        1. Developmental Biology
        2. Personalized Medicine
        3. Regenerative Medicine
        4. Disease Pathology Studies
        5. Drug Toxicity and Efficacy Testing
      4. Middle East and Africa Organoids and Spheroids Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Biotechnology and Pharmaceutical Industries
        2. Academic and Research Institutes
        3. Hospitals and Diagnostic Centers
      5. UAE
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      6. Turkey
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      7. Saudi Arabia
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      8. South Africa
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      9. Egypt
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      10. Nigeria
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      11. Rest of MEA
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
    5. LATAM
      1. LATAM Organoids and Spheroids Market By Type 2022-2034 (USD MILLION/ Units)
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
      2. LATAM Organoids and Spheroids Market By Spheroids 2022-2034 (USD MILLION/ Units)
        1. Multicellular Tumor Spheroids (MCTS)
        2. Neurospheres
        3. Mammospheres
        4. Hepatospheres 
        5. Embryoid bodies
      3. LATAM Organoids and Spheroids Market By Application 2022-2034 (USD MILLION/ Units)
        1. Developmental Biology
        2. Personalized Medicine
        3. Regenerative Medicine
        4. Disease Pathology Studies
        5. Drug Toxicity and Efficacy Testing
      4. LATAM Organoids and Spheroids Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Biotechnology and Pharmaceutical Industries
        2. Academic and Research Institutes
        3. Hospitals and Diagnostic Centers
      5. Brazil
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      6. Mexico
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      7. Argentina
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      8. Chile
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      9. Colombia
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
      10. Rest of LATAM
        1. Organoids
        2. Neural Organoids
        3. Hepatic Organoids
        4. Intestinal Organoids
        5. Multicellular Tumor Spheroids (MCTS)
        6. Neurospheres
        7. Mammospheres
        8. Hepatospheres 
        9. Embryoid bodies
        10. Developmental Biology
        11. Personalized Medicine
        12. Regenerative Medicine
        13. Disease Pathology Studies
        14. Drug Toxicity and Efficacy Testing
        15. Biotechnology and Pharmaceutical Industries
        16. Academic and Research Institutes
        17. Hospitals and Diagnostic Centers
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.